Are there better ways to evaluate how prescribed therapies are working while patients are living their everyday lives, when doctors aren’t there to check? New answers may come from the digital devices we carry and wear, says Donna Coffman, a biostatistician in the College of Public Health. Coffman is leading a National Cancer Institute-funded study of smoking cessation treatments as a way to develop models that could help researchers improve patient responses to all sorts of ongoing therapies, from managing addictive behaviors to compliance with medication-taking.  “We n...